P51948 (MAT1_HUMAN) Homo sapiens (Human)

CDK-activating kinase assembly factor MAT1 UniProtKBInterProSTRINGInteractive Modelling

309 aa; Sequence (Fasta) ; (Isoform 2); 14 identical sequences

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-309
100MG; 17×ZN;SF4;
RNA polymerase II pre-initiation complex with the proximal +1 nucleosome (PIC-Nuc10W) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-308
100.0SF4; 16×ZN;MG;
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
1-308
100.0MG; 16×ZN;SF4;
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-308
100.017×ZN;SF4;MG;
RNA polymerase II pre-initiation complex with the distal +1 nucleosome (PIC-Nuc18W) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-308
100.0SF4; 17×ZN;MG;
Human Mediator with RNA Polymerase II Pre-initiation complex Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; A0JLT2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O43513; O60244; O75586; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7;
1-308
100.0SF4; 18×ZN;MG;
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-308
100.016×ZN;SF4;MG;
Structure of the human apo TFIIH Heteromer
P18074; P19447; P32780; Q13888; Q13889; Q6ZYL4; Q92759;
1-212
100SF4;ZN;
Cryo-EM structure of the human TFIIH core complex Heteromer
P18074; P19447; P32780; Q13888; Q13889; Q6ZYL4; Q92759;
1-210
100SF4;ZN;
Structure of transcribing complex 9 (TC9), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;MG;W0F;
Structure of transcribing complex 5 (TC5), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;MG;W0F;
Structure of transcribing complex 8 (TC8), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;MG;W0F;
Structure of transcribing complex 6 (TC6), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;MG;W0F;
Structure of transcribing complex 3 (TC3), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;W0F;MG;
Structure of transcribing complex 4 (TC4), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;MG;W0F;
Structure of transcribing complex 2 (TC2), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;W0F;MG;
Structure of transcribing complex 7 (TC7), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
1-171
10017×ZN;SF4;MG;W0F;
TFIIH in a pre-translocated state (without ADP-BeF3) Heteromer
P18074; P19447; P29083; P32780; Q13888; Q13889; Q6ZYL4; Q92759;
1-149
100SF4;ZN;
TFIIH in a post-translocated state (with ADP-BeF3) Heteromer
P18074; P19447; P29083; P32780; Q13888; Q13889; Q6ZYL4; Q92759;
1-149
100SF4;ZN;ADP;MG;BEF;
RNA polymerase II pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-149
100SF4; 17×ZN;MG;
RNA polymerase II pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-149
100SF4; 17×ZN;MG;
Helicase domain complex Heteromer
P18074;
66-130
100CL;
Crystal structure of the dual T-loop phosphorylated Cdk7/CycH/Mat1 complex Heteromer
P50613; P51946;
244-308
100EDO;
Cryo-EM structure of CAK in complex with inhibitor ICEC0574 Heteromer
P50613; P51946;
244-308
100X4F;
Structure of the human CDK-activating kinase Heteromer
P50613; P51946;
244-308
100MG;AGS;
Cryo-EM structure of CAK in complex with inhibitor ICEC0880 (ring-up conformation) Heteromer
P50613; P51946;
244-308
100X3Z;
Cryo-EM structure of CAK-THZ1 Heteromer
P50613; P51946;
244-308
100V0G;
Cryo-EM structure of CAK in complex with inhibitor CT7030 Heteromer
P50613; P51946;
244-308
100ZQ6;
Cryo-EM structure of CAK in complex with inhibitor ICEC0880 (ring-down conformation) Heteromer
P50613; P51946;
244-308
100X3Z;
Cryo-EM structure of CAK in complex with inhibitor ICEC0942 Heteromer
P50613; P51946;
244-308
100I74;
Cryo-EM structure of CAK in complex with inhibitor BS-194 Heteromer
P50613; P51946;
244-308
100NS9;
Cryo-EM structure of CAK in complex with nucleotide analogue ATPgS Heteromer
P50613; P51946;
244-308
100AGS;MG;
Cryo-EM structure of CAK in complex with inhibitor ICEC0768 Heteromer
P50613; P51946;
244-308
100X2Z;
Cryo-EM structure of CAK in complex with inhibitor ICEC0829 Heteromer
P50613; P51946;
244-308
100X50;X58;
Cryo-EM structure of CAK in complex with inhibitor BS-181 Heteromer
P50613; P51946;
244-308
100X2H;
Cryo-EM structure of the human CAK bound to ICEC0942 at 2.5 Angstroms resolution Heteromer
P50613; P51946;
244-308
100I74;
Cryo-EM structure of the human CAK bound to ICEC0942 (PHENIX-OPLS3e) Heteromer
P50613; P51946;
244-308
100I74;
Cryo-EM structure of CAK in complex with inhibitor dinaciclib Heteromer
P50613; P51946;
244-308
1001QK;
Cryo-EM structure of CAK in complex with inhibitor ICEC0943 Heteromer
P50613; P51946;
244-308
100I73;
Structure of the human CAK in complex with THZ1 Heteromer
P50613; P51946;
244-308
100V0G;
Cryo-EM structure of CAK in complex with inhibitor ICEC0510-S Heteromer
P50613; P51946;
244-308
100X4Q;
Cryo-EM structure of CAK in complex with inhibitor ICEC0510-R Heteromer
P50613; P51946;
244-308
100X4L;
Cryo-EM structure of CAK in complex with inhibitor ICEC0914 Heteromer
P50613; P51946;
244-308
100X1W;
Cryo-EM structure of CAK with averaged inhibitor density Heteromer
P50613; P51946;
244-308
100
Cryo-EM structure of CDK7 subunit of CAK in complex with inhibitor LDC4297 Heteromer
P50613;
244-296
100.0WD9;
RNA polymerase II pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
67-110
100SF4; 15×ZN;ADP;MG;BEF;
SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE HUMAN TFIIH MAT1 SUBUNITmonomer1-65
100ZN;

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8byq.1.Hmonomer0.631-308
ZN;100.00
7ena.1.Amonomer0.611-306
100.00
6o9l.1.Ymonomer0.611-309
ZN;100.00

3 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28byq.1.Hmonomer0.651-266
ZN;100.00
Isoform 27lbm.1.7monomer0.651-266
ZN;100.00
Isoform 26o9l.1.Ymonomer0.541-267
ZN;100.00